More Company News

ANGLE

Concordance of Parsortix with tissue biopsy
17 Jan 2022Read More

ANGLE

Update on lab accreditation and ovarian study
13 Jan 2022Read More

ANGLE

Insight into drug resistance in NSCLC
10 Jan 2022Read More

ANGLE

Parsortix in RNA analysis of CTCs as tool in NSCLC
01 Dec 2021Read More

ANGLE

Appointment of Chief Medical Officer
15 Nov 2021Read More

ANGLE

Parsortix system showcased at NCRI Festival
11 Nov 2021Read More

ANGLE

Interim H121 results
30 Sep 2021Read More

ANGLE

Parsortix demonstrates ability to isolate CTCs
27 Sep 2021Read More

ANGLE

Study shows use of Parsortix to assess PD-L1
22 Sep 2021Read More

ANGLE

Parsortix enables gene expression analysis in mPCa
20 Sep 2021Read More

1 2 3
Return to ANGLE
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).